Cargando…

Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan

BACKGROUND: Red blood cell (RBC) alloantibodies may be formed following exposure to RBC antigens. In most cases, the alloimmunization develops during pregnancy or from previous blood transfusions. The RBC antigens and their alloantibodies vary among different human populations and ethnic groups, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Joudi, Fawwaz, Ali, Anuar Bin, Ramli, Majdan Bin, Ahmed, Suhair, Ismail, Mohd
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082716/
https://www.ncbi.nlm.nih.gov/pubmed/21572715
http://dx.doi.org/10.4103/0973-6247.75997
_version_ 1782202318867922944
author Al-Joudi, Fawwaz
Ali, Anuar Bin
Ramli, Majdan Bin
Ahmed, Suhair
Ismail, Mohd
author_facet Al-Joudi, Fawwaz
Ali, Anuar Bin
Ramli, Majdan Bin
Ahmed, Suhair
Ismail, Mohd
author_sort Al-Joudi, Fawwaz
collection PubMed
description BACKGROUND: Red blood cell (RBC) alloantibodies may be formed following exposure to RBC antigens. In most cases, the alloimmunization develops during pregnancy or from previous blood transfusions. The RBC antigens and their alloantibodies vary among different human populations and ethnic groups, and they do have a clinical significance for their adverse immunological reactions. AIMS: This study aimed at studying the prevalence of RBC alloantibodies at the Blood Transfusion Unit of Hospital Raja Perempuan Zainab II in Kota Bharu, Malaysia. PATIENTS AND METHODS: A cross-sectional study was performed utilizing data obtained in the years 2007 and 2008. Data of antibody screening tests from 5719 patients were examined. RESULTS AND DISCUSSION: The overall prevalence of alloimmunization was 65 (1.13%). The majority of these had a single alloantibody (76.9%), whereas the remaining 23.1% had multiple antibodies. The anti-E antibody comprised the most common alloantibody (24.6%) followed by the anti-Lewis (a) antibodies (18.5%) and the anti-M antibody (13.8%). There were more female recipients than males. CONCLUSIONS: It was concluded that the findings of this work have been comparable with other published works, and that the main factors associated with alloantibody formation were multiple transfusions and pregnancies. The study also emphasizes the necessity for carrying out immunohematology studies prior to every blood transfusion especially in cases that require multiple transfusions for a long period of time such as in thalassemia patients.
format Text
id pubmed-3082716
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30827162011-05-13 Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan Al-Joudi, Fawwaz Ali, Anuar Bin Ramli, Majdan Bin Ahmed, Suhair Ismail, Mohd Asian J Transfus Sci Original Article BACKGROUND: Red blood cell (RBC) alloantibodies may be formed following exposure to RBC antigens. In most cases, the alloimmunization develops during pregnancy or from previous blood transfusions. The RBC antigens and their alloantibodies vary among different human populations and ethnic groups, and they do have a clinical significance for their adverse immunological reactions. AIMS: This study aimed at studying the prevalence of RBC alloantibodies at the Blood Transfusion Unit of Hospital Raja Perempuan Zainab II in Kota Bharu, Malaysia. PATIENTS AND METHODS: A cross-sectional study was performed utilizing data obtained in the years 2007 and 2008. Data of antibody screening tests from 5719 patients were examined. RESULTS AND DISCUSSION: The overall prevalence of alloimmunization was 65 (1.13%). The majority of these had a single alloantibody (76.9%), whereas the remaining 23.1% had multiple antibodies. The anti-E antibody comprised the most common alloantibody (24.6%) followed by the anti-Lewis (a) antibodies (18.5%) and the anti-M antibody (13.8%). There were more female recipients than males. CONCLUSIONS: It was concluded that the findings of this work have been comparable with other published works, and that the main factors associated with alloantibody formation were multiple transfusions and pregnancies. The study also emphasizes the necessity for carrying out immunohematology studies prior to every blood transfusion especially in cases that require multiple transfusions for a long period of time such as in thalassemia patients. Medknow Publications 2011-01 /pmc/articles/PMC3082716/ /pubmed/21572715 http://dx.doi.org/10.4103/0973-6247.75997 Text en © Asian Journal of Transfusion Science http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Al-Joudi, Fawwaz
Ali, Anuar Bin
Ramli, Majdan Bin
Ahmed, Suhair
Ismail, Mohd
Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan
title Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan
title_full Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan
title_fullStr Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan
title_full_unstemmed Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan
title_short Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan
title_sort prevalence and specificities of red cell alloantibodies among blood recipients in the malaysian state of kelantan
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082716/
https://www.ncbi.nlm.nih.gov/pubmed/21572715
http://dx.doi.org/10.4103/0973-6247.75997
work_keys_str_mv AT aljoudifawwaz prevalenceandspecificitiesofredcellalloantibodiesamongbloodrecipientsinthemalaysianstateofkelantan
AT alianuarbin prevalenceandspecificitiesofredcellalloantibodiesamongbloodrecipientsinthemalaysianstateofkelantan
AT ramlimajdanbin prevalenceandspecificitiesofredcellalloantibodiesamongbloodrecipientsinthemalaysianstateofkelantan
AT ahmedsuhair prevalenceandspecificitiesofredcellalloantibodiesamongbloodrecipientsinthemalaysianstateofkelantan
AT ismailmohd prevalenceandspecificitiesofredcellalloantibodiesamongbloodrecipientsinthemalaysianstateofkelantan